Title:
INHIBITION OF MCH SIGNAL TRANSDUCTION BY 3-(4-CHLOROPHENYL)BENZO[4,5]IMIDAZO[2,1-B]THIAZOLE-6-CARBOXYLIC ACID
Document Type and Number:
WIPO Patent Application WO/2017/171374
Kind Code:
A1
Abstract:
The present invention relates to a function of 3-(4-chlorophenyl)benzo[4,5]imidazo[2,1-b]thiazole-6-carboxylic acid for regulating MCH signal transduction, and contains, as an active ingredient, 3-(4-chlorophenyl)benzo[4,5]imidazo[2,1-b]thiazole-6-carboxylic acid or a salt thereof, thereby being useful in the treatment or prevention of various diseases, such as diabetes, depression, and anxiety, which are associated with the regulation of MCH signal transduction.
More Like This:
Inventors:
KIM CHEOL-HEE (KR)
JUNG SEUNG-HYUN (KR)
HWANG KYU-SEOK (KR)
KIM NAK-JEONG (KR)
BAE MYUNG-AE (KR)
YI KYU-YANG (KR)
JUNG SEUNG-HYUN (KR)
HWANG KYU-SEOK (KR)
KIM NAK-JEONG (KR)
BAE MYUNG-AE (KR)
YI KYU-YANG (KR)
Application Number:
PCT/KR2017/003367
Publication Date:
October 05, 2017
Filing Date:
March 28, 2017
Export Citation:
Assignee:
THE IND & ACAD COOP IN CHUNGNAM NAT UNIV (IAC) (KR)
KOREA RES INST CHEMICAL TECH (KR)
KOREA RES INST CHEMICAL TECH (KR)
International Classes:
A61K31/429; A23L33/10; A61K31/4188
Domestic Patent References:
WO2007039462A2 | 2007-04-12 |
Foreign References:
KR20090126322A | 2009-12-08 | |||
KR20110133044A | 2011-12-09 | |||
KR20130132846A | 2013-12-05 | |||
KR20080108534A | 2008-12-15 | |||
KR101719321B1 | 2017-03-23 |
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
Download PDF:
Previous Patent: COMPOSITION FOR SUPPRESSING RESISTANCE TO EGFR-TARGETING AGENT
Next Patent: COMPOUND, AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME
Next Patent: COMPOUND, AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME